Asia Pacific Glucagon Delivery Device Market Size & Outlook, 2026-2034

Asia Pacific Glucagon Delivery Device Market Insights

Reed Intelligence analysis indicates that the Asia Pacific Glucagon Delivery Device Market size, which was USD 180.21 Million in 2025, is projected to attain USD 438.96 Million by 2034.
The market is expected to register a CAGR of 10.26% over the period 2026–2034.
In 2025, Autoinjectors emerged as the dominant Product Type based on market size.
Prefilled Syringes is projected to register the fastest growth, positioning it as the most attractive Product Type segment over the forecast horizon.

Other Key Findings

Asia Pacific held 15.67% share of the global Glucagon Delivery Device Market size in 2025.
United States is expected to remain the largest contributor to the global market size by 2034.
By 2034, Japan is anticipated to record the highest growth in Asia Pacific, with the market size expected to reach USD 69.6 Million.

Report Summary

Report Scope	Details
Base Year for Study	2025
Study Period	2022-2034
Historical Period	2022-2024
Forecast Period	2026-2034
Market Size In 2025	USD 180.21 Million
Market Size In 2034	USD 438.96 Million
Largest segment	Autoinjectors
Units	Revenue in USD Million
CAGR	10.26% (2026-2034)
Segmnetation Covered
Asia Pacific	China India Japan South Korea Taiwan Australia Singapore South East Asia
Product Type	Autoinjectors Prefilled Syringes Nasal Devices
Application	Severe Hypoglycemia Exercise-Induced Hypoglycemia
End-Use	Hospitals Clinics Homecare Settings
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Asia Pacific Glucagon Delivery Device Market Country 2026-2034 (USD Million)

Asia Pacific	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
China	XX.x	XX.x	XX.x	68.48	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
India	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Japan	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
South Korea	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Taiwan	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Australia	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Singapore	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
South East Asia	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Asia Pacific Glucagon Delivery Device Market Product Type 2026-2034 (USD Million)

Product Type	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Autoinjectors	XX.x	XX.x	XX.x	91.58	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Prefilled Syringes	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Nasal Devices	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Asia Pacific Glucagon Delivery Device Market Application 2026-2034 (USD Million)

Application	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Severe Hypoglycemia	XX.x	XX.x	XX.x	102.63	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Exercise-Induced Hypoglycemia	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Asia Pacific Glucagon Delivery Device Market End-Use 2026-2034 (USD Million)

End-Use	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Hospitals	XX.x	XX.x	XX.x	84.23	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Clinics	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Homecare Settings	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Author :

Reed Intelligence Research Team

The Reed Intelligence Research Team brings together over 15+ years of collective experience in market research, data analytics, and strategic consulting. Comprising seasoned analysts, economists, and industry specialists, the team delivers precise, data-driven insights across sectors including technology, healthcare, energy, manufacturing, and consumer goods. By combining domain expertise with modern analytical tools, they ensure each report meets the highest standards of accuracy and relevance.